ClinicalTrials.gg
Not yet recruitingNCT07275281Updated Dec 30, 2025

Incidental Findings on Coronary Computed Tomography Angiography

An observational study in Computed Tomography, Coronary Angiography and Incidental Findings, sponsored by Jordan Collaborating Cardiology Group. Not yet recruiting at 1 site in Jordan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-30.

Sponsored by Jordan Collaborating Cardiology Group · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
2,000
Ages
18 Years and older
Sex
All
01

Study summary

Coronary CT angiography (CCTA) is increasingly used for ischemic heart disease diagnosis. The rising number of CCTA tests has led to a significant increase in the number of finding unexpected incidental extracardiac diseases.

Read the detailed description

The increasing utilization of coronary computed tomography (CT) angiography (CCTA) to diagnose and triage patients with suspected or known ischemic heart disease has led to a parallel increase in the frequency of incidental findings in the coronaries (nonatherosclerotic), noncoronary cardiac structures and noncardiac structures.

Studies have reported a prevalence of incidental findings on CCTA up to 40%. Most of these findings have no clinical relevance, but some have significant clinical implications in the care and prognosis of the patients.

We sought to assess the frequency of incidental findings on CCTA scans in consecutive studies performed in the past 5 years.

02

Conditions studied

  • Computed Tomography
  • Coronary Angiography
  • Incidental Findings

Keywords

  • Coronary artery disease
  • computed tomography
  • indidental findings
03

In context

Coronary Artery Disease

4,857 studies on the registry are indexed under Coronary Artery Disease; 890 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 320 across 1,687 observational studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

Jordan Collaborating Cardiology Group is the lead sponsor of 26 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

  1. All adult patients who underwent CCTA for chest pain diagnosis.
  2. Scans will be reviewed seeking the presence of coronary non atherosclerotic disease in the coronaries, cardiac structure and non cardiac structures.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients ho underwent CCTA

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
2,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adult patients who underwent CCTA

    All adults (18 years of age and older0 who underwent CCTA to evaluate the coronary arteries in the past 5 years will have their CT scans reviewed for the presence of non coronary incidental findings.

    Diagnostic Test: CCTA (Review of the scans)

Interventions

  • Diagnostic testCCTA (Review of the scans)

    Reviewing coronary scans done in the past 5 years looking for findings other than atherosclerotic coronary artery disease.

06

What researchers measure

Primary outcomes

  1. Non atherosclerotic coronary disease

    Findings other than coronary atherosclerotic disease: coronary bridge, coronary dissection, coronary embolism, and coronary fistula.

    Time frame: BASELINE

  2. Non coronary cardiac findings

    Findings include valve calcifications, left atrial appendage thrombus, patent foramen ovale and septal defects, pericardial effusion, LV clots, cardiac tumors.

    Time frame: BASELINE

  3. Non cardiac findings

    Non cardiac findings include: a. major vascular abnormalities in the aorta and the pulmonary arteries, b. pulmonary disease: masses, lymph nodes, granulomas, and pleural effusion, and c. non pulmonary findings in the diaphragm and the hepatobiliary tree.

    Time frame: BASELINE

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The excel sheet of the incidental findings in the 2000 CCTA scans in possession of the investigators will be available to any physician upon request

Supporting information: Study protocol, Statistical analysis plan

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2026; primary completion for Jan 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 28, 2025
First posted
Dec 10, 2025
StartEst.
Jan 2, 2026
Primary completionEst.
Jan 2, 2027
CompletionEst.
Feb 28, 2027
Last update
Dec 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07275281
Lead sponsor
Jordan Collaborating Cardiology Group
Responsible party
Sponsor
First posted
Dec 10, 2025
Start date
Jan 2, 2026 (estimated)
Primary completion
Jan 2, 2027 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Dec 30, 2025

Study contacts

Wasfi Alghween, MD
Contact
hammoudeh_ayman@yahoo.com
+96265001000
Musa Saadeh
Contact
065001000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion